Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Refinitiv1분 미만 읽기
Exact Therapeutics AS 
EXTX:
EXACT THERAPEUTICS FIRST HALF 2025 INTERIM RESULTS
H1 OPERATING LOSS NOK 45.9 MILLION VERSUS NOK 29.7 MILLION YEAR AGO
이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오